Get started
Author

Wilhelmina Duivenvoorden

Observed names: W C Duivenvoorden, W C M Duivenvoorden, W Duivenvoorden, W. C. M. Duivenvoorden, W. Duivenvoorden, W.C.M Duivenvoorden, W.C.M. Duivenvoorden, WILHELMINA C.M. DUIVENVOORDEN, Wilhelmina C Duivenvoorden, Wilhelmina C M Duivenvoorden, Wilhelmina C. Duivenvoorden, Wilhelmina C. M. Duivenvoorden, Wilhelmina C.M. Duivenvoorden, Wilhelmina CM Duivenvoorden, Wilhelmina CM. Duivenvoorden
Observed institutions: University of Zurich, Juravinski Cancer Centre, Thunder Bay Regional Health Sciences Centre, Juravinski Hospital, ETH Zurich, Fonds de Recherche du Québec - Santé, Sandoz Group AG (Switzerland), Nestec (Switzerland), St. Joseph’s Healthcare Hamilton, Lakehead University, Hamilton Health Sciences, McMaster University
ORCID: 0000-0003-3439-9163
Observed ORCID: 0000-0003-3439-9163
OpenAlex ID: A5022664740
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
2019 · David Margel, Avivit Peer, et al. · The Journal of Urology · 150
Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics
2013 · A Paschos, R Pandya, et al. · Prostate Cancer and Prostatic Diseases · 133
Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.
2002 · Wilhelmina C M Duivenvoorden, Snezana Vukmirović Popović, et al. · PubMed · 127
Transforming growth factor β1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells
1999 · Wilhelmina C.M. Duivenvoorden, Holger W. Hirte, et al. · Clinical & Experimental Metastasis · 102
Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
1997 · W C Duivenvoorden, H W Hirte, et al. · PubMed · 89
GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model
2014 · Sarah N. Hopmans, Wilhelmina C.M. Duivenvoorden, et al. · Urologic Oncology Seminars and Original Investigations · 83
Pathophysiologic interactions in skeletal metastasis
2000 · F. William Orr, Joanne Lee, et al. · Cancer · 79
Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?
2015 · Piotr Zareba, Wilhelmina Duivenvoorden, et al. · Therapeutic Advances in Urology · 74
PDF
Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise
2018 · K. M. Di Sebastiano, J. H. Pinthus, et al. · Obesity Reviews · 66
An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis
2017 · Tomokazu Ishikawa, Tohru Yoneyama, et al. · International Journal of Molecular Sciences · 59
PDF
Synthesis of redox-active ferrocene pyrazole conjugates and their cytotoxicity in human mammary adenocarcinoma MCF-7 cells
2005 · Wilhelmina C.M. Duivenvoorden, You-nian Liu, et al. · Inorganica Chimica Acta · 46
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy
2016 · Wilhelmina C.M. Duivenvoorden, Siamak Daneshmand, et al. · The Journal of Urology · 41
Adiponectin inhibits oxidative stress in human prostate carcinoma cells
2012 · J-P Lu, Z F Hou, et al. · Prostate Cancer and Prostatic Diseases · 41
Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer
2007 · W C M Duivenvoorden, S Vukmirović-Popović, et al. · British Journal of Cancer · 40
PDF
Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms
2015 · Åsa Tivesten, Jehonathan H. Pinthus, et al. · Urologic Oncology Seminars and Original Investigations · 39
Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
2021 · Tohru Yoneyama, Hayato Yamamoto, et al. · The Prostate · 35
Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection
2019 · Tohru Yoneyama, Yuki Tobisawa, et al. · Cancer Science · 31
PDF
PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo
2011 · A P Cumming, S N Hopmans, et al. · Prostate Cancer and Prostatic Diseases · 29
Induction of mitotic aneuploidy using Chinese hamster primary embryonic cells. Test results of 10 chemicals
1993 · A.T. Natarajan, W.C.M. Duivenvoorden, et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 29
Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells
2009 · Faryar Foroodi, Wilhelmina C. Duivenvoorden, et al. · Anti-Cancer Drugs · 28
Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy
2006 · C Richard, W Duivenvoorden, et al. · Cancer Gene Therapy · 24
Morphological, histomorphometric, and microstructural alterations in human bone metastasis from breast carcinoma
2002 · S Vukmirovic-Popovic, N Colterjohn, et al. · Bone · 24
Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma
2000 · Šárka Lhoták, Leelamma J. Elavathil, et al. · Clinical & Experimental Metastasis · 24
Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation
2015 · WILHELMINA C.M. DUIVENVOORDEN, SARAH N. HOPMANS, et al. · Oncology Reports · 22
PDF
Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention
2018 · Piotr Zareba, Wilhelmina C.M. Duivenvoorden, et al. · Bladder Cancer · 21
PDF
Works count: 80
Citation count: 1,642
H-index: 23
I10-index: 35
Year
Topic
Type